☆ 4.7 Article

Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

Myocarditis after Covid-19 Vaccination in a Large Health Care Organization

Guy Witberg et al.

Summary: Among 2.5 million patients who received the BNT162b2 mRNA vaccine in a large Israeli health care system, the incidence of myocarditis at 42 days was 2.13 cases per 100,000 persons, with the highest incidence (10.69 per 100,000 persons) among male patients between the ages of 16 and 29 years. Most cases of myocarditis were mild or moderate.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

D. Mevorach et al.

Summary: The incidence of myocarditis increased after receiving the BNT162b2 vaccine in Israel, particularly after the second dose among young male recipients. The clinical presentation of myocarditis after vaccination was usually mild.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Trends in Acute Myocarditis Related Pediatric Hospitalizations in the United States, 2007-2016

Rhythm Vasudeva et al.

Summary: This study found that the incidence of pediatric acute myocarditis in the United States has been increasing annually, while the in-hospital mortality rate has been decreasing. The occurrence of congestive heart failure remained stable, while hospitalization costs have been increasing annually with stable length of stay. Future studies are needed to investigate long-term outcomes related to acute myocarditis.

AMERICAN JOURNAL OF CARDIOLOGY (2021)

Add to Collection

Review Immunology

US Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines

Diane Gubernot et al.

Summary: The COVID-19 pandemic has led to global collaborative efforts to develop vaccines, with mass vaccination campaigns underway in multiple countries. Monitoring vaccine safety and understanding background incidence rates are crucial for assessing adverse events related to vaccination.

VACCINE (2021)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Myocarditis After BNT162b2 and mRNA-1273 Vaccination

Kathryn F. Larson et al.

CIRCULATION (2021)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Myocarditis Temporally Associated With COVID-19 Vaccination

Carolyn M. Rosner et al.

CIRCULATION (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Diagnosis and Management of Myocarditis in Children A Scientific Statement From the American Heart Association

Yuk M. Law et al.

Summary: Myocarditis remains a clinical challenge in pediatrics, with diagnostic focus shifting from endomyocardial biopsy to clinical suspicion and cardiac magnetic resonance imaging. The presentation of myocarditis varies widely, ranging from minimal symptoms to severe complications like heart failure or cardiogenic shock. Despite advances in understanding and management, the lack of a universally accepted definition for myocarditis hinders progress in targeted therapy.

CIRCULATION (2021)

Add to Collection

Letter Medicine, General & Internal

Myocarditis and Pericarditis After Vaccination for COVID-19

George A. Diaz et al.

Summary: This study compares the incidence of myocarditis and pericarditis in emergency department or inpatient hospital encounters before and during the period of COVID-19 vaccination availability in a large US health care system.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Pediatrics

Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination

Mayme Marshall et al.

Summary: This report presents 7 cases of acute myocarditis or myopericarditis in healthy male adolescents following the second dose of Pfizer-BioNTech COVID-19 vaccination, with patients rapidly recovering their symptoms through treatment with nonsteroidal anti-inflammatory drugs, intravenous immunoglobulin, and corticosteroids. The potential association between vaccine administration and myocarditis requires further monitoring and investigation.

PEDIATRICS (2021)

Add to Collection

Article Immunology

Myocarditis following COVID-19 mRNA vaccination

Saif Abu Mouch et al.

Summary: This study reported six cases of myocarditis occurring shortly after BNT162b2 vaccination, all in young males with mild clinical course. All patients responded to the vaccine, and myocarditis post-BNT162b2 vaccination may be considered an adverse reaction.

VACCINE (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

Julia W. Gargano et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021

Tegan K. Boehmer et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military

Jay Montgomery et al.

Summary: This study investigated cases of myocarditis occurring in male patients within the US Military Health System after receiving mRNA COVID-19 vaccines between January and April 2021. A total of 23 male patients presented with acute chest pain within 4 days post-vaccination, with elevated troponin levels and findings consistent with myocarditis on imaging. The number of cases observed was higher than expected after a second dose of the vaccine among male military members.

JAMA CARDIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination

Han W. Kim et al.

Summary: This study described 7 patients with acute myocarditis, 4 of whom had received mRNA COVID-19 vaccination. All patients presented with severe chest pain, biomarker evidence of myocardial injury, and were hospitalized. Cardiac magnetic resonance imaging findings were typical for myocarditis. Further investigation is needed to determine associations of COVID-19 vaccination and myocarditis.

JAMA CARDIOLOGY (2021)

Add to Collection

Article Computer Science, Interdisciplinary Applications

The REDCap consortium: Building an international community of software platform partners

Paul A. Harris et al.

JOURNAL OF BIOMEDICAL INFORMATICS (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prognostic Value of Repeating Cardiac Magnetic Resonance in Patients With Acute Myocarditis

Giovanni Donato Aquaro et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Add to Collection

Review Cardiac & Cardiovascular Systems

Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation Expert Recommendations

Vanessa M. Ferreira et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Occurrence and Features of Childhood Myocarditis: A Nationwide Study in Finland

Anita Arola et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

Analysis of Clinical Parameters and Cardiac Magnetic Resonance Imaging as Predictors of Outcome in Pediatric Myocarditis

Shagun Sachdeva et al.

AMERICAN JOURNAL OF CARDIOLOGY (2015)

Add to Collection

Review Cardiac & Cardiovascular Systems

Viral myocarditis-diagnosis, treatment options, and current controversies

Ari Pollack et al.

NATURE REVIEWS CARDIOLOGY (2015)

Add to Collection

Review Immunology

Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)

Tom T. Shimabukuro et al.

VACCINE (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

The effects of gender and age on occurrence of clinically suspected myocarditis in adulthood

Ville Kyto et al.

HEART (2013)

Add to Collection

Article Cardiac & Cardiovascular Systems

2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Clyde W. Yancy et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)

Add to Collection

Article Cardiac & Cardiovascular Systems

Comparison of the Clinical Presentation, Treatment, and Outcome of Fulminant and Acute Myocarditis in Children

Tsutomu Saji et al.

CIRCULATION JOURNAL (2012)

Add to Collection

Article Cardiac & Cardiovascular Systems

Demographics, Trends, and Outcomes in Pediatric Acute Myocarditis in the United States, 2006 to 2011

Sunil J. Ghelani et al.

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2012)

Add to Collection

Review Medicine, General & Internal

Medical Progress: Myocarditis.

Leslie T. Cooper

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Add to Collection

Article Cardiac & Cardiovascular Systems

Presentation, patterns of myocardial damage, and clinical course of viral myocarditis

Heiko Mahrholdt et al.

CIRCULATION (2006)

Add to Collection

Article Medicine, General & Internal

Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel

JS Halsell et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.